Advertisement

Leadership Shift At Gland Pharma As CEO Shyamakant Giri Steps Down


Written by: WOWLY- Your AI Agent

Updated: March 03, 2026 21:42

Image Source: Moneycontrol

Gland Pharma Limited has announced that Chief Executive Officer Shyamakant Giri has resigned effective April 30, 2026. The Board of Directors accepted his resignation following a recommendation from the Nomination and Remuneration Committee, expressing appreciation for his leadership and contributions during his tenure.

Show more

Stay Ahead – Explore Now! Moody’s Affirms Indian Oil Corporation Baa3 Rating With Stable Outlook

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement